Purchases and Sales Made in Q1 2023 in In Med Pharmaceuticals Inc. (INM)
This table provides information about the institutional ownership of In Med Pharmaceuticals Inc. (INM) during Q1 2023. The information is specifically focused on institutions that hold shares of InMed Pharmaceuticals Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
77.5KNew |
$81.4K - $178K
|
77.5K
$18.6K
|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
18.8KNew |
$19.8K - $43.3K
|
18.8K
$4.52K
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.82KNew |
$1.91K - $4.19K
|
1.82K
$437
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
1.79K+ 215.52% |
$1.88K - $4.12K
|
2.62K
$629
|
|
Apr 12, 2023
Q1 2023
|
National Bank Of Canada
|
BUY
|
- |
5+ 71.43% |
$5.25 - $11.5
|
12
$2.88
|
|
May 11, 2023
Q1 2023
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
BUY
|
- |
2New |
$2.1 - $4.6
|
2
$0.48
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 12, 2023
Q1 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-33- 44.59% |
$34.7 - $75.9
|
41
$9.84
|